Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C42H66O14 |
| Molecular Weight | 794.965 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 20 / 20 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]6(O[C@H]1CC[C@@]2(C)[C@@]([H])(CC[C@]3(C)[C@]2([H])CC=C4[C@]5([H])[C@@H](C)[C@H](C)CC[C@@]5(CC[C@@]34C(O)=O)C(O)=O)C1(C)C)O[C@H](C)[C@H](O)[C@H](O[C@]7([H])O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O
InChI
InChIKey=BZXXSUZFEIFGEX-LCSOEGAZSA-N
InChI=1S/C42H66O14/c1-19-10-15-41(36(49)50)16-17-42(37(51)52)22(27(41)20(19)2)8-9-25-39(6)13-12-26(38(4,5)24(39)11-14-40(25,42)7)55-35-32(48)33(28(44)21(3)53-35)56-34-31(47)30(46)29(45)23(18-43)54-34/h8,19-21,23-35,43-48H,9-18H2,1-7H3,(H,49,50)(H,51,52)/t19-,20+,21-,23-,24+,25-,26+,27+,28+,29-,30+,31-,32-,33+,34+,35+,39+,40-,41+,42-/m1/s1
| Molecular Formula | C42H66O14 |
| Molecular Weight | 794.965 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 20 / 20 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
DescriptionCurator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/2553871
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/2553871
Quinovic acid glycoside 2 was isolated from the bark of Uncaria tomentosa, the Peruvian flora, widely used in local medicine for the treatment of cancer, arthritis, gastritis and certain epidermic diseases. Quinovic acid glycoside 2 demonstrated efficacy against vesicular stomatitis virus infection in vitro.
Originator
Approval Year
Sample Use Guides
Confluent monolayers of CER cells in 6-well plates were infected with 200 uL of a virus dilution containing approx. 100 plaque forming units (pfu). Following a 1h adsorption period at 37C, the cells were added with an overlay medium containing doubling concentrations of compounds and incubated until plaques developed (36-48 h at 37C). The antiviral activity of the compounds was expressed as the minimal inhibitory concentration (MIC50) required to reduce the plaque number by 50% with respect to control infected cells. The MIC50 for Quinovic acid glycoside 2 (compound 3) was 25 uM.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 02:15:15 UTC 2023
by
admin
on
Sat Dec 16 02:15:15 UTC 2023
|
| Record UNII |
P84Z2WDZ9J
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
115569-78-3
Created by
admin on Sat Dec 16 02:15:15 UTC 2023 , Edited by admin on Sat Dec 16 02:15:15 UTC 2023
|
PRIMARY | |||
|
P84Z2WDZ9J
Created by
admin on Sat Dec 16 02:15:15 UTC 2023 , Edited by admin on Sat Dec 16 02:15:15 UTC 2023
|
PRIMARY | |||
|
44593500
Created by
admin on Sat Dec 16 02:15:15 UTC 2023 , Edited by admin on Sat Dec 16 02:15:15 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
